Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma.

Chapman BC, Gleisner A, Rigg D, Meguid C, Goodman K, Brauer B, Gajdos C, Schulick RD, Edil BH, McCarter MD.

J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.25004. [Epub ahead of print]

PMID:
29448308
2.

Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy.

Torphy RJ, Schulick RD, Zhu Y.

Int J Mol Sci. 2017 Dec 6;18(12). pii: E2642. doi: 10.3390/ijms18122642. Review.

3.

Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?

Torphy RJ, Schulick RD.

Surg Clin North Am. 2018 Feb;98(1):25-35. doi: 10.1016/j.suc.2017.09.003. Review.

PMID:
29191275
4.

Correction to: International Scholarship Programs of the American College of Surgeons: Expansion of the Global Surgical Network.

Nigri G, Early K, Tsoulfas G, Ferreres A, Ferrone CR, Schulick R, Al-Refaie WB, Turner PL, Velmahos G.

World J Surg. 2017 Nov 10. doi: 10.1007/s00268-017-4330-y. [Epub ahead of print]

PMID:
29127463
5.

Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.

Chapman BC, Gajdos C, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Gleisner A, Schulick RD, McCarter MD, Edil BH.

Surg Endosc. 2017 Oct 24. doi: 10.1007/s00464-017-5915-0. [Epub ahead of print]

PMID:
29067580
6.

What We Learned From John Cameron.

Schulick RD.

Ann Surg. 2018 Feb;267(2S Suppl 2):S3-S5. doi: 10.1097/SLA.0000000000002576. No abstract available.

PMID:
29064886
7.

International Scholarship Programs of the American College of Surgeons: Expansion of the Global Surgical Network.

Nigri G, Early K, Tsoulfas G, Ferreres A, Ferrone CR, Schulick R, Al-Refaie WB, Turner PL, Velmahos G.

World J Surg. 2017 Oct 20. doi: 10.1007/s00268-017-4284-0. [Epub ahead of print] Erratum in: World J Surg. 2017 Nov 10;:.

PMID:
29058065
8.

Cancer-promoting mechanisms of tumor-associated neutrophils.

Hurt B, Schulick R, Edil B, El Kasmi KC, Barnett C Jr.

Am J Surg. 2017 Nov;214(5):938-944. doi: 10.1016/j.amjsurg.2017.08.003. Epub 2017 Aug 10. Review.

PMID:
28830617
9.

Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms.

Chapman BC, Gleisner A, Ibrahim-Zada I, Overbey DM, Paniccia A, Meguid C, Brauer B, Gajdos C, McCarter MD, Schulick RD, Edil BH.

Surg Endosc. 2018 Feb;32(2):915-922. doi: 10.1007/s00464-017-5766-8. Epub 2017 Aug 4.

PMID:
28779245
10.

Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.

Xu F, Sunderland A, Zhou Y, Schulick RD, Edil BH, Zhu Y.

Cancer Immunol Immunother. 2017 Oct;66(10):1367-1375. doi: 10.1007/s00262-017-2031-x. Epub 2017 Jun 16.

PMID:
28623459
11.

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MHG.

J Clin Oncol. 2017 Jul 10;35(20):2324-2328. doi: 10.1200/JCO.2017.72.4948. Epub 2017 Apr 11.

PMID:
28398845
12.

Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer.

Chapman BC, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Messersmith W, Lieu C, Stiegmann GV, Schulick RD, Gajdos C.

J Surg Oncol. 2017 Jun;115(8):1033-1044. doi: 10.1002/jso.24613. Epub 2017 Mar 23.

PMID:
28334436
13.

An institutional analysis of unplanned return to the operating room to identify areas for quality improvement.

Lin Y, Meguid RA, Hosokawa PW, Henderson WG, Hammermeister KE, Schulick RD, Shelstad RC, Wild TT, McIntyre RC Jr.

Am J Surg. 2017 Jul;214(1):1-6. doi: 10.1016/j.amjsurg.2016.10.021. Epub 2016 Dec 13.

PMID:
28057294
14.

The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.

Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M; International Study Group on Pancreatic Surgery (ISGPS).

Surgery. 2017 Mar;161(3):584-591. doi: 10.1016/j.surg.2016.11.014. Epub 2016 Dec 28. Review.

PMID:
28040257
15.

Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, Messersmith W, McCarter MD, Gleisner A, Edil BH, Schulick RD, Gajdos C.

J Am Coll Surg. 2017 Mar;224(3):362-372. doi: 10.1016/j.jamcollsurg.2016.11.011. Epub 2016 Dec 5.

PMID:
27923615
16.

Hypermutation In Pancreatic Cancer.

Humphris JL, Patch AM, Nones K, Bailey PJ, Johns AL, McKay S, Chang DK, Miller DK, Pajic M, Kassahn KS, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Stone A, Wilson PJ, Anderson M, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Mead RS, Xu Q, Wu J, Pinese M, Cowley MJ, Jones MD, Nagrial AM, Chin VT, Chantrill LA, Mawson A, Chou A, Scarlett CJ, Pinho AV, Rooman I, Giry-Laterriere M, Samra JS, Kench JG, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, McKay CJ, Carter CR, Dickson EJ, Graham JS, Duthie F, Oien K, Hair J, Morton JP, Sansom OJ, Grützmann R, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Rusev B, Corbo V, Salvia R, Cataldo I, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Hofmann O, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Gill AJ, Pearson JV, Grimmond SM, Waddell N, Biankin AV.

Gastroenterology. 2017 Jan;152(1):68-74.e2. doi: 10.1053/j.gastro.2016.09.060. Epub 2016 Nov 15.

PMID:
27856273
17.

Evolving Trends Towards Minimally Invasive Surgery for Solid-Pseudopapillary Neoplasms.

Stewart CL, Meguid C, Chapman B, Schulick R, Edil BH.

Ann Surg Oncol. 2016 Dec;23(13):4165-4168. Epub 2016 Aug 10.

PMID:
27510845
18.

Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm.

Chapman BC, Paniccia A, Ryan C, Schulick RD, Edil BH.

Ann Surg Oncol. 2017 Feb;24(2):560. doi: 10.1245/s10434-016-5481-z. Epub 2016 Sep 2.

PMID:
27590330
19.

Total laparoscopic pancreaticoduodenectomy.

Paniccia A, Chapman B, Edil BH, Schulick RD.

J Vis Surg. 2016 Aug 2;2:130. doi: 10.21037/jovs.2016.07.13. eCollection 2016.

20.

The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients.

Meguid C, Schulick RD, Schefter TE, Lieu CH, Boniface M, Williams N, Vogel JD, Gajdos C, McCarter M, Edil BH.

Ann Surg Oncol. 2016 Nov;23(12):3986-3990. Epub 2016 Jun 24.

PMID:
27342825
21.

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MH.

J Clin Oncol. 2016 Jul 20;34(21):2541-56. doi: 10.1200/JCO.2016.67.5553. Epub 2016 May 31.

PMID:
27247221
22.

Key Tenets of Effective Surgery Leadership: Perspectives From the Society of Surgical Chairs Mentorship Sessions.

Rosengart TK, Kent KC, Bland KI, Britt LD, Eberlein TJ, Gewertz BL, Hunter JG, Lillemoe KD, Pellegrini CA, Schulick RD, Stain SC, Weigel RJ.

JAMA Surg. 2016 Aug 1;151(8):768-70. doi: 10.1001/jamasurg.2016.0405.

PMID:
27096328
23.

A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB).

Paniccia A, Hosokawa PW, Schulick RD, Henderson W, Kaplan J, Gajdos C.

Surgery. 2016 Aug;160(2):281-92. doi: 10.1016/j.surg.2016.02.025. Epub 2016 Apr 14.

PMID:
27085687
24.

Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.

Abdelfatah E, Guzzetta AA, Nagarajan N, Wolfgang CL, Pawlik TM, Choti MA, Schulick R, Montgomery EA, Meyer C, Thornton K, Herman J, Terezakis S, Frassica D, Ahuja N.

J Surg Oncol. 2016 Jul;114(1):56-64. doi: 10.1002/jso.24256. Epub 2016 Apr 13.

25.

Main-duct Intraductal Papillary Mucinous Neoplasm. High Cancer Risk in Duct Diameter of 5 to 9 mm.

Del Chiaro M, Schulick RD.

Ann Surg. 2017 Dec;266(6):e86. doi: 10.1097/SLA.0000000000001725. No abstract available.

PMID:
27043742
26.

Pancreatic Neuroendocrine Tumors: an Update.

Paniccia A, Edil BH, Schulick RD.

Indian J Surg. 2015 Oct;77(5):395-402. doi: 10.1007/s12262-015-1360-2. Epub 2015 Oct 13.

27.

Establishing a framework for building multidisciplinary programs.

Meguid C, Ryan CE, Edil BH, Schulick RD, Gajdos C, Boniface M, Schefter TE, Purcell WT, McCarter M.

J Multidiscip Healthc. 2015 Dec 2;8:519-26. doi: 10.2147/JMDH.S96415. eCollection 2015.

28.

Outcomes of arterial resection during pancreatectomy for tumor.

Glebova NO, Hicks CW, Tosoian JJ, Piazza KM, Abularrage CJ, Schulick RD, Wolfgang CL, Black JH 3rd.

J Vasc Surg. 2016 Mar;63(3):722-9.e1. doi: 10.1016/j.jvs.2015.09.042. Epub 2015 Nov 21.

PMID:
26610641
29.

Predictors for Surgical Referral in Patients With Pancreatic Cystic Lesions Undergoing Endoscopic Ultrasound: Results From a Large Multicenter Cohort Study.

Ge PS, Gaddam S, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Ghassemi KF, Sedarat A, Watson RR, Amateau SK, Brauer BC, Yen RD, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter MD, Gajdos C, Attwell AR, Muthusamy VR, Early DS, Wani S.

Pancreas. 2016 Jan;45(1):51-7. doi: 10.1097/MPA.0000000000000386.

PMID:
26262589
30.

A combination of molecular markers and clinical features improve the classification of pancreatic cysts.

Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, Kinde I, Blackford A, Raman SP, Wolfgang CL, Tomita T, Niknafs N, Douville C, Ptak J, Dobbyn L, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Cummings OW, Brand RE, Zeh HJ, Singhi AD, Scarpa A, Salvia R, Malleo G, Zamboni G, Falconi M, Jang JY, Kim SW, Kwon W, Hong SM, Song KB, Kim SC, Swan N, Murphy J, Geoghegan J, Brugge W, Fernandez-Del Castillo C, Mino-Kenudson M, Schulick R, Edil BH, Adsay V, Paulino J, van Hooft J, Yachida S, Nara S, Hiraoka N, Yamao K, Hijioka S, van der Merwe S, Goggins M, Canto MI, Ahuja N, Hirose K, Makary M, Weiss MJ, Cameron J, Pittman M, Eshleman JR, Diaz LA Jr, Papadopoulos N, Kinzler KW, Karchin R, Hruban RH, Vogelstein B, Lennon AM.

Gastroenterology. 2015 Nov;149(6):1501-10. doi: 10.1053/j.gastro.2015.07.041. Epub 2015 Aug 4.

31.

Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study.

Gaddam S, Ge PS, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Watson RR, Ghassemi KF, Sedarat A, Komanduri S, Jaiyeola DM, Brauer BC, Yen RD, Amateau SK, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter M, Gajdos C, Attwell A, Muthusamy VR, Early DS, Wani S.

Gastrointest Endosc. 2015 Dec;82(6):1060-9. doi: 10.1016/j.gie.2015.04.040. Epub 2015 Jun 12.

PMID:
26077458
32.

Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.

Paniccia A, Hosokawa P, Henderson W, Schulick RD, Edil BH, McCarter MD, Gajdos C.

JAMA Surg. 2015 Aug;150(8):701-10. doi: 10.1001/jamasurg.2015.0668.

PMID:
26062046
33.

Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection.

Glebova NO, Hicks CW, Piazza KM, Abularrage CJ, Cameron AM, Schulick RD, Wolfgang CL, Black JH 3rd.

J Vasc Surg. 2015 Aug;62(2):424-33. doi: 10.1016/j.jvs.2015.01.061. Epub 2015 May 4.

34.

Total Laparoscopic Pancreaticoduodenectomy: A Single-Institutional Experience.

Paniccia A, Schulick RD, Edil BH.

Ann Surg Oncol. 2015 Dec;22(13):4380-1. doi: 10.1245/s10434-015-4450-2. Epub 2015 Apr 18.

PMID:
25893407
35.

Challenges of minimally invasive pancreas surgery growth with such a high learning curve.

Edil BH, Schulick RD.

JAMA Surg. 2015 May;150(5):423. doi: 10.1001/jamasurg.2015.32. No abstract available.

PMID:
25760810
36.

Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.

Byers JT, Paniccia A, Kaplan J, Koenig M, Kahn N, Wilson L, Chen L, Schulick RD, Edil BH, Zhu Y.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1574-9. doi: 10.1245/s10434-014-4293-2. Epub 2014 Dec 18.

PMID:
25519928
37.

Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study.

Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD.

Medicine (Baltimore). 2014 Dec;93(27):e198. doi: 10.1097/MD.0000000000000198.

38.

PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.

Soares KC, Rucki AA, Wu AA, Olino K, Xiao Q, Chai Y, Wamwea A, Bigelow E, Lutz E, Liu L, Yao S, Anders RA, Laheru D, Wolfgang CL, Edil BH, Schulick RD, Jaffee EM, Zheng L.

J Immunother. 2015 Jan;38(1):1-11. doi: 10.1097/CJI.0000000000000062.

39.

A preclinical murine model of hepatic metastases.

Soares KC, Foley K, Olino K, Leubner A, Mayo SC, Jain A, Jaffee E, Schulick RD, Yoshimura K, Edil B, Zheng L.

J Vis Exp. 2014 Sep 27;(91):51677. doi: 10.3791/51677.

40.

Clearing common bile duct stones: one size does not fit all.

Montero P, Schulick RD.

JAMA Surg. 2014 Oct;149(10):1014. doi: 10.1001/jamasurg.2014.195. No abstract available.

PMID:
25134062
41.

Racial disparities in breast cancer: more bad news.

Murphy CD, Schulick RD.

JAMA Surg. 2014 Aug;149(8):796-7. doi: 10.1001/jamasurg.2014.44. No abstract available.

PMID:
24943995
42.

A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.

Zheng L, Edil BH, Soares KC, El-Shami K, Uram JN, Judkins C, Zhang Z, Onners B, Laheru D, Pardoll D, Jaffee EM, Schulick RD.

Ann Surg Oncol. 2014 Nov;21(12):3931-7. doi: 10.1245/s10434-014-3844-x. Epub 2014 Jun 19.

43.

Intercellular adhesion molecule-1 mediates murine colon adenocarcinoma invasion.

Howard K, Lo KK, Ao L, Gamboni F, Edil BH, Schulick R, Barnett CC Jr.

J Surg Res. 2014 Mar;187(1):19-23. doi: 10.1016/j.jss.2013.11.001. Epub 2013 Nov 8.

44.

Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.

Faisal F, Tsai HL, Blackford A, Olino K, Xia C, De Jesus-Acosta A, Le DT, Cosgrove D, Azad N, Rasheed Z, Diaz LA Jr, Donehower R, Laheru D, Hruban RH, Fishman EK, Edil BH, Schulick R, Wolfgang C, Herman J, Zheng L.

Am J Clin Oncol. 2016 Feb;39(1):18-26. doi: 10.1097/COC.0000000000000022.

45.

Bridging the gap from T to K: integrated surgical research fellowship for the next generation of surgical scientists.

Moore HB, Moore EE, Nehler MR, Cicutto LC, Bacon AW, Travis C, Schulick RD.

J Am Coll Surg. 2014 Feb;218(2):279-82. doi: 10.1016/j.jamcollsurg.2013.10.026. Epub 2013 Nov 12. Review. No abstract available.

46.

Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships.

Dholakia AS, Hacker-Prietz A, Wild AT, Raman SP, Wood LD, Huang P, Laheru DA, Zheng L, De Jesus-Acosta A, Le DT, Schulick R, Edil B, Ellsworth S, Pawlik TM, Iacobuzio-Donahue CA, Hruban RH, Cameron JL, Fishman EK, Wolfgang CL, Herman JM.

J Radiat Oncol. 2013 Dec;2(4):413-425. doi: 10.1007/s13566-013-0115-6. Epub 2013 Sep 22.

47.

Sometimes consensus and expert opinion is the best we can do.

Schulick RD.

JAMA Surg. 2014 Jan;149(1):25. doi: 10.1001/jamasurg.2013.3987. No abstract available.

PMID:
24225739
48.

Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.

McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH.

Am J Surg Pathol. 2013 Nov;37(11):1671-7. doi: 10.1097/PAS.0000000000000089.

49.

Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium?

Singhi AD, Norwood S, Liu TC, Sharma R, Wolfgang CL, Schulick RD, Zeh HJ, Hruban RH.

Am J Surg Pathol. 2013 Sep;37(9):1329-35. doi: 10.1097/PAS.0b013e3182a1ad72.

PMID:
24076773
50.

Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.

Herman JM, Fan KY, Wild AT, Wood LD, Blackford AL, Donehower RC, Hidalgo M, Schulick RD, Edil BH, Choti MA, Hruban RH, Pawlik TM, Cameron JL, Laheru DA, Iacobuzio-Donahue CA, Wolfgang CL.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):458-9. doi: 10.1016/j.ijrobp.2013.06.2039. No abstract available.

Supplemental Content

Loading ...
Support Center